BiomX
Closed (deSPAC)Profile in progress
- What it is
- Inc
- What it’s doing now
- Merging with Chardan Healthcare Acquisition Corp. (PHGE) — closed (despac).
- What you should know
- The deal carries a $50M minimum-cash condition — heavy redemptions can break it.
The business, per its filings
SEC primaryInc. BiomX Inc. is a company focused on acquiring and further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response sectors. The Company’s portfolio is built around the growing need for earlier and more accurate threat detection, particularly as UAVs and other autonomous systems play a larger role in defense and homeland security.
What the company says about itself
Web research — not auditedBiomX builds detection, analysis, and response solutions for defense, security, and critical infrastructure. The company offers systems for identifying physical threats across land, sea, and aerial environments, including aerial drone technologies and AI-driven intelligence platforms. Its leadership includes former senior IDF officers, intelligence officials, and defense technologists.
- Markets:
- Defense | Security
- Products:
- Detection Systems | Aerial Systems | Integrated Security Systems | Intelligence Systems
[WEB-INTEL 2026-08-26] 5 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Concurrent $50M Financing" [https://www.microbiometimes.com/biomx-announces-entry-into-merger-agreement-with-adaptive-phage-therapeutics-and-concurrent-50-million-financing/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "BiomX has raised a total of $56M over 7 funding rounds: 2 Early-Stage, 4 Post IPO and 1 Grant (prize money) rounds." [https://tracxn.com/d/companies/biomx/__jFuFEhiQJ4NI8NLWydJiNxEe57xBr0mYO4ZqHe2eHiY/funding-and-investors] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "BIOMx has raised $12M in total disclosed funding. The most recent round on record is a Series B round of $12M in February 2025." [https://startupfundraising.com/companies/biomx] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "BIOMx has raised $56.0M across 2 funding rounds. Most recently, it raised $32.0M Series B in February 2019." [https://startupintros.com/orgs/biomx] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "BiomX will acquire 10% of MEA for $50000 plus 1.3M shares" [https://www.stocktitan.net/sec-filings/PHGE/8-k-biom-x-inc-reports-material-event-65fed81104ce.html]
Source: https://biomx.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.
The deal it’s entering
BiomX is merging with Chardan Healthcare Acquisition Corp. (PHGE) currently marked Closed (deSPAC).
| Headline equity value | — |
| PIPE | ≈ $3M · unsourced |
| Minimum cash to close | $50M |
Structure per SEC accession(s) 0001213900-25-126161, 0001213900-19-018757. How to read these numbers: headline vs effective valuation · what a definitive agreement commits
What exactly is being valued, and at what
Common questions
Is BiomX going public?
BiomX has an approved merger with the SPAC Chardan Healthcare Acquisition Corp. (PHGE). Deal status: Closed (deSPAC).
Does BiomX have revenue?
The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.
Educational content, not investment advice.